$8.13
0.172.14%
At Close: -
$8.13
00.00%
After Hours: 4:00 PM EDT
15 minutes delayed
Comments
Loading...
Outlook Therapeutics
OTLKNASDAQ
Outlook Therapeutics (NASDAQ:OTLK) Stock, Earnings Estimates, EPS, And Revenue
Outlook Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 12
EPS Estimate
$-1.010
Quarterly Revenue Estimate
–
Annual Revenue
(as of Mar 31)
(as of Mar 31)
–
Analyze the earnings history of Outlook Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| OTLK | Outlook Therapeutics | -$1.60 | -$1.01 | — | — | $0.00 | — | — | — | 08/12/2024 | Get Alert |
| OTLK | Outlook Therapeutics | -$0.52 | -$0.85 | -$1.55 | -82.35% | $0.00 | — | $0.00 | — | 05/15/2024 | Get Alert |
| OTLK | Outlook Therapeutics | -$1.60 | — | -$0.80 | — | $0.00 | — | $0.00 | — | 02/14/2024 | Get Alert |
| OTLK | Outlook Therapeutics | -$1.20 | — | -$1.00 | — | $0.00 | — | $0.00 | — | 12/22/2023 | Get Alert |
| OTLK | Outlook Therapeutics | -$1.60 | -$1.00 | -$1.60 | -60.00% | $0.00 | — | $0.00 | — | 08/14/2023 | Get Alert |
| OTLK | Outlook Therapeutics | -$1.80 | -$1.20 | -$0.60 | 50.00% | $0.00 | — | $0.00 | — | 05/15/2023 | Get Alert |
| OTLK | Outlook Therapeutics | -$1.40 | -$0.80 | -$1.60 | -100.00% | $0.00 | — | $0.00 | — | 02/14/2023 | Get Alert |
| OTLK | Outlook Therapeutics | -$1.60 | -$1.40 | -$1.20 | 14.29% | $0.00 | — | $0.00 | — | 12/29/2022 | Get Alert |
| OTLK | Outlook Therapeutics | -$1.40 | — | -$1.60 | — | $0.00 | — | $0.00 | — | 08/10/2022 | Get Alert |
| OTLK | Outlook Therapeutics | -$1.80 | — | -$1.80 | — | $0.00 | — | $0.00 | — | 05/13/2022 | Get Alert |
| OTLK | Outlook Therapeutics | -$2.40 | -$1.20 | -$1.40 | -16.67% | $0.00 | — | $0.00 | — | 02/14/2022 | Get Alert |
| OTLK | Outlook Therapeutics | -$0.60 | -$1.20 | -$1.60 | -33.33% | $0.00 | $300.00K | $0.00 | -100.00% | 12/22/2021 | Get Alert |
| OTLK | Outlook Therapeutics | -$0.60 | -$1.40 | -$1.40 | 0.00% | $0.00 | $320.00K | $0.00 | -100.00% | 08/13/2021 | Get Alert |
| OTLK | Outlook Therapeutics | -$2.60 | -$1.80 | -$1.80 | 0.00% | $0.00 | $320.00K | $0.00 | -100.00% | 05/14/2021 | Get Alert |
| OTLK | Outlook Therapeutics | -$12.40 | — | -$2.40 | — | $0.00 | — | $0.00 | — | 02/16/2021 | Get Alert |
| OTLK | Outlook Therapeutics | -$39.60 | — | -$0.60 | — | $5.85M | — | $0.00 | — | 12/23/2020 | Get Alert |
| OTLK | Outlook Therapeutics | -$4.80 | — | -$2.20 | — | $584.00K | — | $0.00 | — | 08/14/2020 | Get Alert |
| OTLK | Outlook Therapeutics | -$11.60 | — | -$2.60 | — | $641.00K | — | $0.00 | — | 05/15/2020 | Get Alert |
| OTLK | Outlook Therapeutics | -$20.00 | — | -$12.40 | — | — | — | $0.00 | — | 02/14/2020 | Get Alert |
| OTLK | Outlook Therapeutics | — | — | $1.00 | — | — | — | $5.85M | — | 12/19/2019 | Get Alert |
| OTLK | Outlook Therapeutics | -$42.00 | — | -$4.80 | — | — | — | $584.00K | — | 08/14/2019 | Get Alert |
Outlook Therapeutics (OTLK) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-15 | $-1.55 | $-0.85 | -82.3 % |
| Jun 2023 | 2023-08-14 | $-1.60 | $-1.00 | -60.0 % |
| Mar 2023 | 2023-05-15 | $-0.60 | $-1.20 | 50.0 % |
| Dec 2022 | 2023-02-14 | $-1.60 | $-0.80 | -100.0 % |
Outlook Therapeutics (OTLK) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Sep 2021 | 2021-12-22 | $0 | $300.00K | -100.0 % |
| Jun 2021 | 2021-08-13 | $0 | $320.00K | -100.0 % |
| Mar 2021 | 2021-05-14 | $0 | $320.00K | -100.0 % |
FAQ
When is Outlook Therapeutics (NASDAQ:OTLK) reporting earnings?
Outlook Therapeutics (OTLK) is scheduled to report earnings on August 12, 2024. The last reported earnings were for reported on May 15, 2024 for Q2.
What were the latest earnings per share (EPS) for Outlook Therapeutics (NASDAQ:OTLK)?
The Actual EPS was $-1.55, which missed the estimate of $-0.85.
What were Outlook Therapeutics’s (NASDAQ:OTLK) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.